Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome.
The Mendelian tumour syndromes hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary paragangliomatosis with phaeochromocytomas (HPGL) result from mutations in nuclear genes (FH and SDHB/C/D, respectively) that encode Krebs cycle enzymes. HPGL tumours are highly vascular and there i...
Main Authors: | Pollard, P, Wortham, N, Barclay, E, Alam, A, Elia, G, Manek, S, Poulsom, R, Tomlinson, I |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2005
|
Registos relacionados
-
Aberrant expression of apoptosis proteins and ultrastructural aberrations in uterine leiomyomas from patients with hereditary leiomyomatosis and renal cell carcinoma.
Por: Wortham, N, et al.
Publicado em: (2006) -
Aberrant expression of apoptosis proteins and ultrastructural aberrations in uterine leiomyomas from patients with hereditary leiomyomatosis and renal cell carcinoma
Por: Wortham, N, et al.
Publicado em: (2006) -
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency.
Por: Alam, N, et al.
Publicado em: (2003) -
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency
Por: Alam, N, et al.
Publicado em: (2003) -
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.
Por: Menko, F, et al.
Publicado em: (2014)